D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Navient
NAVI
$819M
| $4.91M | 0.01% |
285,122
-285,222
| -50% | -$5.14M |
|
|
JKS
1702
PUT
JinkoSolar
JKS
$764M
| $4.91M | 0.01% |
161,600
+80,800
| +100% | +$2.9M |
|
1703
PUT
Union Pacific
UNP
$174B
| $4.91M | 0.01% |
24,100
-37,000
| -61% | -$8.06M |
|
1704
CALL
Huntsman Corp
HUN
$2.1B
| $4.88M | 0.01% |
+200,000
| New | +$5.42M |
|
1705
Americold
COLD
$4.21B
| $4.88M | 0.01% |
160,394
+54,851
| +52% | +$1.77M |
|
1706
Daktronics
DAKT
$946M
| $4.87M | 0.01% |
546,465
-133,709
| -20% | -$1.06M |
|
1707
Mercury Insurance
MCY
$6B
| $4.87M | 0.01% |
173,894
-63,391
| -27% | -$1.87M |
|
1708
Radian Group
RDN
$5.28B
| $4.86M | 0.01% |
193,494
+116,258
| +151% | +$3.07M |
|
1709
PUT
GitLab
GTLB
$5.75B
| $4.86M | 0.01% |
+107,400
| New | +$5.14M |
|
1710
CALL
Carlyle Group
CG
$16.1B
| $4.86M | 0.01% |
161,000
+61,000
| +61% | +$1.97M |
|
1711
Voyager Therapeutics
VYGR
$181M
| $4.85M | 0.01% |
626,123
-321,850
| -34% | -$2.94M |
|
1712
MiMedx Group
MDXG
$630M
| $4.84M | 0.01% |
663,713
-311,217
| -32% | -$2.32M |
|
1713
FuboTV Inc
FUBO
$260M
| $4.84M | 0.01% |
150,974
-205,791
| -58% | -$6.37M |
|
1714
Core Laboratories
CLB
$455M
| $4.83M | 0.01% |
201,327
+98,413
| +96% | +$2.42M |
|
1715
Mobileye
MBLY
$2.02B
| $4.82M | 0.01% |
116,122
-349,311
| -75% | -$13.4M |
|
1716
Pacira BioSciences
PCRX
$1.04B
| $4.82M | 0.01% |
157,062
+151,753
| +2,858% | +$5.47M |
|
|
OLO
1717
DELISTED
Olo Inc
OLO
| $4.82M | 0.01% |
794,748
+138,659
| +21% | +$906K |
|
1718
Popular Inc
BPOP
$11B
| $4.82M | 0.01% |
76,419
+3,273
| +4% | +$216K |
|
1719
CALL
Automatic Data Processing
ADP
$109B
| $4.81M | 0.01% |
20,000
| – | – |
|
1720
Target
TGT
$66.3B
| $4.81M | 0.01% |
43,511
-17,445
| -29% | -$2.21M |
|
1721
PUT
Teva Pharmaceuticals
TEVA
$40.4B
| $4.81M | 0.01% |
471,600
+75,000
| +19% | +$698K |
|
1722
Masco
MAS
$14.3B
| $4.79M | 0.01% |
89,539
+30,055
| +51% | +$1.73M |
|
1723
PUT
Visa
V
$677B
| $4.78M | 0.01% |
20,800
-170,100
| -89% | -$40.9M |
|
|
FFWM
1724
DELISTED
First Foundation Inc
FFWM
| $4.77M | 0.01% |
784,011
-372,839
| -32% | -$2.46M |
|
|
OSG
1725
Octave Specialty Group
OSG
$257M
| $4.76M | 0.01% |
394,977
+64,908
| +20% | +$872K |
|
Similar funds
D.E. Shaw & Co's Q3 2023 Portfolio in Review
As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
- D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
- D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.